{
    "organizations": [],
    "uuid": "fee86bc0d393e68029830f362a222c38ea1be4d2",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/01/30/pr-newswire-array-biopharma-to-report-financial-results-for-the-second-quarter-of-fiscal-2018-on-february-6-2018.html",
    "ord_in_thread": 0,
    "title": "Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2018 On February 6, 2018",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "BOULDER, Colo., Jan. 30, 2018 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the second quarter of fiscal 2018 and hold a conference call to discuss those results on Tuesday, February 6, 2018. Ron Squarer, Chief Executive Officer, will lead the call.\nDate:\nTuesday, February 6, 2018\nTime:\n9:00 a.m. Eastern Time\nToll-Free:\n(844) 464-3927\nToll:\n(765) 507-2598\nPass Code:\n6187887\nWebcast, including Replay and Conference Call Slides:\nhttps://edge.media-server.com/m6/p/gwxnqcbs\nAbout Array BioPharma\nArray BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).\nCONTACT:\nArray BioPharma\nAndrea N. Flynn, Ph.D.\nSenior Director, Investor Relations & Corporate Communications\n(303) 381-6600\nir@arraybiopharma.com\nView original content with multimedia: http://www.prnewswire.com/news-releases/array-biopharma-to-report-financial-results-for-the-second-quarter-of-fiscal-2018-on-february-6-2018-300589831.html\nSOURCE Array BioPharma Inc.",
    "published": "2018-01-30T17:00:00.000+02:00",
    "crawled": "2018-01-30T18:30:29.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "boulder",
        "array",
        "biopharma",
        "nasdaq",
        "arry",
        "report",
        "financial",
        "result",
        "second",
        "quarter",
        "fiscal",
        "hold",
        "conference",
        "call",
        "discus",
        "result",
        "tuesday",
        "february",
        "ron",
        "squarer",
        "chief",
        "executive",
        "officer",
        "lead",
        "call",
        "date",
        "tuesday",
        "february",
        "time",
        "eastern",
        "time",
        "toll",
        "pas",
        "code",
        "webcast",
        "including",
        "replay",
        "conference",
        "call",
        "slide",
        "http",
        "array",
        "biopharma",
        "array",
        "biopharma",
        "biopharmaceutical",
        "company",
        "focused",
        "discovery",
        "development",
        "commercialization",
        "targeted",
        "small",
        "molecule",
        "drug",
        "treat",
        "patient",
        "afflicted",
        "cancer",
        "nine",
        "registration",
        "study",
        "currently",
        "advancing",
        "related",
        "seven",
        "partnered",
        "drug",
        "binimetinib",
        "mek162",
        "encorafenib",
        "lgx818",
        "selumetinib",
        "partnered",
        "astrazeneca",
        "danoprevir",
        "partnered",
        "roche",
        "ipatasertib",
        "partnered",
        "genentech",
        "larotrectinib",
        "partnered",
        "loxo",
        "oncology",
        "tucatinib",
        "partnered",
        "cascadian",
        "therapeutic",
        "contact",
        "array",
        "biopharma",
        "andrea",
        "flynn",
        "senior",
        "director",
        "investor",
        "relation",
        "corporate",
        "communication",
        "ir",
        "view",
        "original",
        "content",
        "multimedia",
        "http",
        "source",
        "array",
        "biopharma",
        "inc"
    ]
}